ACTIVE INGREDIENT: Finasteride
STRENGTH & PACK SIZE & GMS CODES:
5 mg Film-coated Tablets X 28 ~ 55355
Treatment and control of benign prostatic hyperplasia (BPH) to cause regression of the enlarged prostate, improve urinary flow and symptoms associated with BPH, reduce the incidence of acute urinary retention and reduce need for surgery.
Fintrid 5 mg tablets should be administered in patients with an enlarged prostate (prostate volume above ca. 40 ml).